Targazyme
Pre-clinicalTo develop and commercialize best-in-class enzyme biopharmaceuticals that enable precise & multi-fold delivery of therapeutic cells to diseased tissues with maximum residence time and therapeutic potency, to cure and even prevent life-threatening cancers, serious auto-immune and neurodegenerative diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $17.5M
About
To develop and commercialize best-in-class enzyme biopharmaceuticals that enable precise & multi-fold delivery of therapeutic cells to diseased tissues with maximum residence time and therapeutic potency, to cure and even prevent life-threatening cancers, serious auto-immune and neurodegenerative diseases.
Cell & Gene Therapy
Funding History
2Total raised:$17.5M
Series A$15MJun 15, 2020
Seed$2.5MJun 15, 2018